NNC 45-0095
NNC 45-0095 is a chemical compound used in medical research. It is a potent and selective antagonist for the glutamate receptor subtype known as the NMDA receptor.
Pronunciation
The pronunciation of NNC 45-0095 is "en-en-see forty-five zero-zero-nine-five".
Etymology
The term "NNC 45-0095" is a systematic name, derived from the naming conventions of the pharmaceutical company Novo Nordisk, where "NNC" stands for "Novo Nordisk Compound", and "45-0095" is a unique identifier for this specific compound.
Related Terms
- Glutamate receptor: A type of protein found in nerve cells that is activated by the neurotransmitter glutamate.
- NMDA receptor: A subtype of glutamate receptor that is important for controlling synaptic plasticity and memory function.
- Antagonist: A substance that interferes with or inhibits the physiological action of another.
- Neurotransmitter: Chemicals that transmit signals from a neuron to a target cell across a synapse.
- Synaptic plasticity: The ability of synapses to strengthen or weaken over time, in response to increases or decreases in their activity.
See Also
External links
- Medical encyclopedia article on NNC 45-0095
- Wikipedia's article - NNC 45-0095
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski